Megacon 600 Tablets

Adult dose

1 tablet once daily after meals.

Child dose

1 tablet once daily after meals.

This medication should not be taken by individuals with excessive calcium in the blood, unknown systemic inflammatory diseases, or kidney diseases. People who are allergic to this medication or its ingredients should also avoid taking it. Infants under 3 months old or those with kidney stones should not take this medication. It is important not to take this medication with levodopa during treatment. Children under 1 year old, individuals currently undergoing treatment by a physician, children receiving adequate sunlight and normal meals, pregnant women or those who may become pregnant, breastfeeding women, premature infants, and young children should consult a physician or pharmacist before taking this medication. Particular caution is needed as the vitamin D component can be transmitted through breast milk, potentially resulting in calcium overload in newborns. Individuals with a history of kidney stones should also consult a specialist before taking this medication. If symptoms such as nausea, vomiting, diarrhea, oral inflammation, constipation, loss of appetite, skin rashes, hives, itching, or swelling occur while taking this medication, discontinue use immediately and consult a physician or pharmacist. Additionally, long-term high-dose intake of pyridoxine can cause nerve damage. Caution should be exercised in patients with folic acid deficiency when receiving excessive doses of vitamin B12 as it may lead to hematologic reactions. High doses may exacerbate peptic ulcers, impair glucose metabolism, raise uric acid levels, and can cause liver damage. If mistakenly taken in excess or if symptoms do not improve after a month of use, consult a specialist immediately. This medication must be taken according to the prescribed dosing and guidance, and supervision from a guardian is required when given to children. Urine may turn yellow during use, which can affect clinical test results. This medication should be kept out of reach of children, stored in a cool, dry place, away from direct sunlight, and tightly closed to maintain quality. Moreover, do not transfer to another container to preserve the quality of the medication.

Serious side effects

• Hives, severe swelling (swelling and fluid retention - in patients with renal failure or heart failure).
• Swelling may correspond to severe swelling or urinary disturbances.

Mild side effects

• Nausea, vomiting, diarrhea, loose stools, stomatitis (oral inflammation), constipation, loss of appetite, erythema, eczema, rash, papular rash, itching, swelling, may cause urine to turn yellow.
• Possible occurrence of sensory neuropathy or neurological symptoms (peripheral nerve dysfunction).
• Hematologic adverse reactions (high-dose administration of vitamin B12 in patients with folic acid deficiency).
• Possibility of exacerbating peptic ulcers, glucose tolerance impairment, hyperuricemia, and liver damage.
• Adverse reactions in the event of overdose.

Drug interactions

Do not take this medication with levodopa.

This medication should be stored in a sealed container to prevent air or moisture ingress. It is advisable to maintain room temperature between 1 degree and 30 degrees. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance

Brown rectangular film-coated tablets

Package unit

90 tablets/CASE (45 tablets/bottle * 2)